SPINEART TO BREAK 10% THRESHOLD IN FRANCE
Geneva, October 28th 2008. Spineart, leader of a new spinal generation, announces the appointment of Mr. Jean-Claude Donnarel as its Director of French Sales. Jean-Claude joins with a 14 year experience in managing leading French sales teams, having served as Director of Stryker Howmedica’s trauma unit, and then as General Manager of Medtronic spine. Stéphane Mugnier, Spineart co-CEO and head of Marketing & Sales said: ” We are proud to welcome Jean-Claude as the head of our French Sales force. Thanks to his vast experience in the spine business in France, and having managed the leading sales team there, we believe that we will be able to continue our striking expansion. Spineart has already reached 9% of the French spinal market share and clearly has the capacity and ambition to do much better with the reinforcement of its sales force as well as the continuous roll-out of its innovative but simple spinal implants.”
MINIMALLY INVASIVE TLIF CAGE SUCCESSFULLY LAUNCHED
Geneva, October 16th 2008. Spineart, leader of a new spinal generation, announces the completion of its innovative range of lumbar fusion implants with the launch of its minimally invasive TLIF cage. The JULIET®TL benefits from the range’s typical slit, designed to stimulate the fusion by exposing the graft to tension (according to Wolff’s law). The JULIET®TL can be implanted through a minimally invasive transforaminal approach in order to achieve maximum efficiency and minimal disruption. Dr. Frischhmuth from the Neurosurgical department at the Elbeklinikum in Stade, Germany, states:” Once again, Spineart has managed to simplify our work, shortening surgery time and reducing the number of tools necessary, whilst giving the surgeons and patients the benefits of a less traumatic approach.”
500 CERVICAL DISC PROTHESES BAGUERA®C IMPLANTED WORLDWIDE
Geneva, March 30th 2008. After a year of commercialisation, Spineart is proud to announce the 500th implantation outside US of its unique pre-assembled, MRI compatible, easy to implant BAGUERA®C cervical disc.
FIRST IMPLANTATION OF LAMINOPLASTY STAPLE TRYPTIK®LA
Geneva, March 1st 2008. Spineart announces the first implantation of its laminoplasty staple, TRYPTIK®LA, by Dr. Mangione, spine specialist based in Bordeaux, France. This easy to implant staple will soon be available to the market, proving again Spineart’s ability to develop a complete range of innovative and dedicated spinal implants.
LUMBAR DISC PROSTHESIS BAGUERA®L LAUNCHED
Geneva, February 11th 2008. Spineart, leader of a new spinal generation, announces its first lumbar artificial disc surgery, BAGUERA®L. Dr. Morad Pedram, spine surgeon in Bordeaux, France, successfully performed the first lumbar surgery utilizing SpineArt’s new generation of motion implants, BAGUERA®L. This artificial disc is MRI compatible, benefits from our patented shock absorption system, a unique choice of a fixed or mobile PE inlay during the operation, and like all of our innovative products can be easily implanted with a set of high quality ancillaries. For the BAGUERA®L, the set of ancillaries is comprised of only 7 well designed tools. Dr. Morad Pedram commented: “I was extremely satisfied by the very small number of steps which characterize the simple implantation procedure of SpineArt’s lumbar disc.”
DISTRIBUTION EXPANDING AT BREATHTAKING PACE
Geneva, October 8th 2007. Spineart’s has signed a number of key distribution partnerships, including Germany, Spain, Argentina, Venezuela, and is now covering over 14 countries. In Spain, Spineart has reached an exclusive distribution contract and aims to reach a 5% market share within one year. In Latin America, SpineArt has signed two exclusive distribution contracts in Argentina and Venezuela, and is going to soon follow suit with Brazil and Mexico. Stéphane Mugnier, co-CEO and Head of Sales and Marketing, said:” Two years after its launch, Spineart already distributes its full line of innovative fusion implants, as well as its cervical artificial disc, BAGUERA®C, covering 80% of all spinal pathologies, in over 14 different countries. By the end of 2008, Spineart expect to cover three continents and distribute our full line of innovative products in over 20 countries, as Spineart expand our sales and marketing team and continue to roll out a new generation of implants.